Skip to content
10-Q

Quarterly Report

BIOSCIENCE HEALTH INNOVATIONS INC. BHIC

0001185185-23-000816

← back to feed
Filed
Aug 11, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 8, 2023 40.39M sh
Cash And Equivalents Q2 2023 · Jun 30, 2023 $30.32K
Cash And Equivalents Q2 2023 · Dec 31, 2022 $11.57K
Current Assets Q2 2023 · Jun 30, 2023 $62.97K
Current Assets Q2 2023 · Dec 31, 2022 $31.61K
Total Assets Q2 2023 · Jun 30, 2023 $62.97K
Total Assets Q2 2023 · Dec 31, 2022 $31.61K
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$11.16K
Stockholders Equity Q2 2023 · Jun 30, 2022 −$2.82K
Stockholders Equity Q2 2023 · Mar 31, 2022 −$944
Stockholders Equity Q2 2023 · Dec 31, 2021 −$1.01K
Sga Expense Q2 2023 · Jun 30, 2022 $8.45K
Sga Expense Q2 2023 · Jun 30, 2022 $8.6K
Net Income Q2 2023 · Jun 30, 2022 −$1.88K
Net Income Q2 2023 · Jun 30, 2022 −$6.09K
Net Income Q2 2023 · Mar 31, 2022 −$4.21K
Operating Income Q2 2023 · Jun 30, 2022 −$1.88K
Operating Income Q2 2023 · Jun 30, 2022 −$6.09K
Gross Profit Q2 2023 · Jun 30, 2022 $7.07K
Gross Profit Q2 2023 · Jun 30, 2022 $7.28K
Cost Of Revenue Q2 2023 · Jun 30, 2022 $982
Cost Of Revenue Q2 2023 · Jun 30, 2022 $1.05K
Revenue Q2 2023 · Jun 30, 2022 $8.05K
Revenue Q2 2023 · Jun 30, 2022 $8.33K